This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

Merck fails to ban Indian diabetes generics


Merck is the latest multinational pharma company to suffer a setback in India, after failing to win an injunction against generic versions of two anti-diabetes drugs.

merck, januvia, janumet, zita, zita met, glenmark


Payment types accepted